Published in Br J Cancer on June 01, 1999
Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov (2010) 4.66
Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer (2010) 3.84
Mechanisms of Taxol resistance related to microtubules. Oncogene (2003) 3.16
Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc Natl Acad Sci U S A (2001) 2.00
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol (2010) 1.82
Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents. Br J Cancer (2009) 1.32
Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy. Cancer Res (2010) 1.18
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br J Cancer (2000) 1.12
Src family kinases and paclitaxel sensitivity. Cancer Biol Ther (2011) 1.05
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials. Ann Oncol (2011) 1.01
Increased expression of class III beta-tubulin in castration-resistant human prostate cancer. Br J Cancer (2009) 1.00
Regulation of intestinal epithelial cells transcriptome by enteric glial cells: impact on intestinal epithelial barrier functions. BMC Genomics (2009) 0.99
Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells. Breast Cancer Res (2004) 0.98
The roles of beta-tubulin mutations and isotype expression in acquired drug resistance. Cancer Inform (2007) 0.98
Recent advances in the chemistry and biology of new generation taxoids. J Nat Prod (2009) 0.98
Beta class II tubulin predominates in normal and tumor breast tissues. Breast Cancer Res (2003) 0.97
βIII-tubulin: a novel mediator of chemoresistance and metastases in pancreatic cancer. Oncotarget (2015) 0.90
Nek4 status differentially alters sensitivity to distinct microtubule poisons. Cancer Res (2010) 0.88
Conformational analysis of the carboxy-terminal tails of human beta-tubulin isotypes. Biophys J (2007) 0.88
Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines. World J Gastroenterol (2001) 0.88
Mechanisms of resistance to cabazitaxel. Mol Cancer Ther (2014) 0.87
Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines. Cancer Cell Int (2013) 0.87
Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells. Br J Cancer (2001) 0.85
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive marker. Oncologist (2013) 0.84
No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin. BMC Cancer (2005) 0.84
Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms. Cancer Cell Int (2014) 0.82
Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III beta-tubulin. Bioorg Med Chem Lett (2009) 0.81
Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells. Br J Pharmacol (2001) 0.80
Nanoparticle-mediated drug delivery for treating melanoma. Nanomedicine (Lond) (2015) 0.79
Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis. BMC Res Notes (2012) 0.78
Induction of neural differentiation in rat C6 glioma cells with taxol. Brain Behav (2015) 0.77
The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer. Curr Genomics (2008) 0.77
Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells. Yonsei Med J (2013) 0.76
Aurora B expression modulates paclitaxel response in non-small cell lung cancer. Br J Cancer (2017) 0.75
Analysis of Beta-Tubulin Gene Exon 4 Mutations in Advanced Stage III or IV Gastric Cancer. J Clin Biochem Nutr (2007) 0.75
[Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)]. Wien Med Wochenschr (2007) 0.75
An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance. Int J Mol Sci (2017) 0.75
Dynamic instability of microtubule growth. Nature (1984) 20.32
Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta (1990) 5.55
Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem (1997) 5.51
Gene inhibition using antisense oligodeoxynucleotides. Nature (1994) 3.26
Multiple forms of tubulin: different gene products and covalent modifications. Int Rev Cytol (1998) 3.03
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest (1997) 2.96
Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol (1998) 2.78
Identification of conserved isotype-defining variable region sequences for four vertebrate beta tubulin polypeptide classes. Proc Natl Acad Sci U S A (1986) 2.71
Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc Natl Acad Sci U S A (1994) 2.17
Taxol: mechanisms of action and resistance. J Natl Cancer Inst Monogr (1993) 1.88
Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin. J Biol Chem (1990) 1.71
Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes. Biochemistry (1997) 1.66
Characterization of the taxol binding site on the microtubule. 2-(m-Azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of beta-tubulin. J Biol Chem (1995) 1.56
Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells. Br J Cancer (1998) 1.46
Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance. J Biol Chem (1995) 1.36
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). Cancer Res (1996) 1.23
Cellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell Biol (1992) 1.22
Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance. Cancer Res (1996) 1.16
Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833. Oncol Res (1995) 1.09
Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides. Mol Pharmacol (1996) 1.09
Overexpression of an epitope-tagged beta-tubulin in Chinese hamster ovary cells causes an increase in endogenous alpha-tubulin synthesis. Cell Motil Cytoskeleton (1995) 1.02
Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents. Biochim Biophys Acta (1998) 1.02
Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides. Biochem Pharmacol (1996) 0.98
Promotion of microtubule assembly in vitro by taxol. Nature (1979) 12.73
Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A (1980) 8.94
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest (1997) 2.96
Taxol binds to polymerized tubulin in vitro. J Cell Biol (1981) 2.86
The effect of aphidicolin on adenovirus DNA synthesis. Nucleic Acids Res (1979) 2.47
Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst (1991) 2.33
Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res (1998) 1.99
Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin Cancer Res (2000) 1.97
Taxol binds to cellular microtubules. J Cell Biol (1982) 1.91
Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. J Biol Chem (1981) 1.74
Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated proteins. Biochemistry (1981) 1.71
The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci U S A (1988) 1.69
Studies on camptothecin. I. Effects of nucleic acid and protein synthesis. Mol Pharmacol (1971) 1.66
Characterization of the Taxol binding site on the microtubule. Identification of Arg(282) in beta-tubulin as the site of photoincorporation of a 7-benzophenone analogue of Taxol. J Biol Chem (1999) 1.59
Characterization of the taxol binding site on the microtubule. 2-(m-Azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of beta-tubulin. J Biol Chem (1995) 1.56
3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin. J Biol Chem (1994) 1.53
A role for ferrous ion and oxygen in the degradation of DNA by bleomycin. Biochem Biophys Res Commun (1976) 1.52
Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes. J Biol Chem (1989) 1.52
A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc Natl Acad Sci U S A (1999) 1.49
Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells. Biochemistry (1976) 1.48
Properties and products of the degradation of DNA by bleomycin and iron(II). Biochemistry (1978) 1.47
Origin of malondialdehyde from DNA degraded by Fe(II) x bleomycin. J Biol Chem (1980) 1.47
Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther (1984) 1.44
Microtubule arrays in taxol-treated mouse dorsal root ganglion-spinal cord cultures. Brain Res (1981) 1.38
Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance. J Biol Chem (1995) 1.36
Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res (2001) 1.32
Effect of chelating agents and metal ions on the degradation of DNA by bleomycin. Biochemistry (1978) 1.31
Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin. Biochem Biophys Res Commun (1971) 1.29
3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. J Med Chem (1990) 1.28
Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines. Mol Cancer Ther (2001) 1.28
Steganacin: an inhibitor of HeLa cell growth and microtubule assembly in vitro. Biochem Biophys Res Commun (1978) 1.23
A common pharmacophore for Taxol and the epothilones based on the biological activity of a taxane molecule lacking a C-13 side chain. Biochemistry (2000) 1.22
Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett (1998) 1.20
Taxol-induced neuropathy: short-term effects of local injection. J Neurocytol (1984) 1.19
Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem (1989) 1.18
The DNA cleavage mechanism of iron-bleomycin. Kinetic resolution of strand scission from base propenal release. J Biol Chem (1986) 1.17
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel. Clin Cancer Res (2001) 1.17
Taxol, a microtubule stabilizing agent, blocks the replication of Trypanosoma cruzi. Proc Natl Acad Sci U S A (1981) 1.15
Mechanism of bleomycin action: in vitro studies. Life Sci (1981) 1.12
Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model. Med Pediatr Oncol (2000) 1.10
Biologically active taxol analogues with deleted A-ring side chain substituents and variable C-2' configurations. J Med Chem (1991) 1.10
Direct photoaffinity labeling of tubulin with taxol. J Natl Cancer Inst (1992) 1.09
Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells. Mol Cell Biol (1990) 1.08
Electrophoretic analysis of P-glycoproteins produced by mouse J774.2 and Chinese hamster ovary multidrug-resistant cells. J Natl Cancer Inst (1988) 1.08
Differential transport properties of two mdr gene products are distinguished by progesterone. J Biol Chem (1990) 1.07
Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. Mol Pharmacol (2001) 1.06
Taxol: mechanisms of action and resistance. Ann N Y Acad Sci (1986) 1.06
Trifluoperazine inhibits phagocytosis in a macrophagelike cultured cell line. J Cell Biol (1981) 1.06
Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells. Biochemistry (1976) 1.03
Distinct P-glycoprotein precursors are overproduced in independently isolated drug-resistant cell lines. Proc Natl Acad Sci U S A (1988) 1.02
Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol Reprod Dev (1990) 1.02
Mechanism of action of the 12,13-epoxytrichothecene, anguidine, an inhibitor of protein synthesis. Biochim Biophys Acta (1976) 1.02
Preparation and biological activity of taxol acetates. Biochem Biophys Res Commun (1984) 1.02
Oxygenated iron bleomycin. A short-lived intermediate in the reaction of ferrous bleomycin with O2. J Biol Chem (1979) 1.01
Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. Mol Pharmacol (1976) 1.01
The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells. Exp Cell Res (2001) 1.01
Effects of camptothecin on the breakage and repair of DNA during the cell cycle. Cancer Res (1973) 1.01
A phosphoglycoprotein associated with taxol resistance in J774.2 cells. Cancer Res (1985) 1.00
Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-alpha gene expression and cytotoxicity. Cancer Res (1994) 0.99
Iron-bleomycin interactions with oxygen and oxygen analogues. Effects on spectra and drug activity. J Biol Chem (1979) 0.99
Identification of the major phosphorylation domain of murine mdr1b P-glycoprotein. Analysis of the protein kinase A and protein kinase C phosphorylation sites. J Biol Chem (1993) 0.98
P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid. Int J Cancer (1992) 0.98
Taxol mediates serine phosphorylation of the 66-kDa Shc isoform. Cancer Res (2000) 0.97
Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b. J Biol Chem (1991) 0.97
Phosphorylation of the multidrug resistance associated glycoprotein. Biochemistry (1987) 0.96
Mössbauer study of iron bleomycin and its activation intermediates. J Biol Chem (1983) 0.94
Stoichiometry of DNA strand scission and aldehyde formation by bleomycin. J Biol Chem (1982) 0.94
Effect of ATP and other nucleotides on the bleomycin-induced degradation of vaccinia virus DNA. Virology (1976) 0.94
Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein. J Biol Chem (1990) 0.94
Morphological alterations in dorsal root ganglion neurons and supporting cells of organotypic mouse spinal cord-ganglion cultures exposed to taxol. Neuroscience (1983) 0.92
Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Cancer Res (1978) 0.92
Biosynthesis of heterogeneous forms of multidrug resistance-associated glycoproteins. J Biol Chem (1987) 0.92
Characterization of the association of radiolabeled bleomycin A2 with HeLa cells. Cancer Res (1984) 0.91
Structure-activity study of cytotoxicity and microtubule assembly in vitro by taxol and related taxanes. Biochem Biophys Res Commun (1982) 0.90
Effects of O2 on the reactions of activated bleomycin. J Biol Chem (1982) 0.90
Redox potential of iron-bleomycin. Biochemistry (1981) 0.89
Conformational analysis of podophyllotoxin and its congeners. Structure--activity relationship in microtubule assembly. J Med Chem (1979) 0.88
Progesterone regulates the murine multidrug resistance mdr1b gene. J Biol Chem (1993) 0.88
Effect of light and oxygen on neocarzinostatin stability and DNA-cleaving activity. J Biol Chem (1978) 0.88
Structural and functional analysis of the mouse mdr1b gene promoter. J Biol Chem (1991) 0.88
Identification of the in vivo phosphorylation sites for acidic-directed kinases in murine mdr1b P-glycoprotein. J Biol Chem (1997) 0.88
Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepilone. Ann Oncol (2006) 0.87
Taxol binds differentially to flagellar outer doublets and their reassembled microtubules. Cell Motil (1983) 0.86
Stimulation of iron(II) bleomycin activity by phosphate-containing compounds. Biochemistry (1985) 0.86
The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies. Chem Biol (2001) 0.86
Taxol: a new probe for studying the structure and function of microtubules. Cold Spring Harb Symp Quant Biol (1982) 0.86
Effect of alkaline pH on taxol-microtubule interactions. J Pharmacol Exp Ther (1991) 0.85
Bleomycin, an inhibitor of vaccinia virus replication. Virology (1974) 0.85
Three distinct nuclear protein binding sites in the promoter of the murine multidrug resistance mdr1b gene. J Biol Chem (1993) 0.85
The involvement of a LINE-1 element in a DNA rearrangement upstream of the mdr1a gene in a taxol multidrug-resistant murine cell line. J Biol Chem (1992) 0.85
On the total synthesis and preliminary biological evaluations of 15(R) and 15(S) aza-dEpoB: a Mitsunobu inversion at C15 in pre-epothilone fragments. Org Lett (2000) 0.84
Bleomycin-DNA interactions: fluorescence and proton magnetic resonance studies. Biochemistry (1977) 0.84
Chemical synthesis of radiolabeled bleomycin A2 and its binding to DNA. Cancer Res (1981) 0.84
Use of antibodies to probe membrane glycoproteins associated with drug-resistant J774.2 cells. Biochem Biophys Res Commun (1987) 0.84
Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium. J Pharmacol Exp Ther (1987) 0.83
Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins. Biochem Pharmacol (1988) 0.82
Alternate overexpression of two P-glycoprotein [corrected] genes is associated with changes in multidrug resistance in a J774.2 cell line. J Biol Chem (1989) 0.82
Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry. Clin Cancer Res (1996) 0.82